Dr Helen Fawcett
BMS Menopause Specialist
Dr Fawcett is a Specialist Menopause Consultant accredited by the British Menopause Society
Dr Sophie Hulme
With a special interest in Post Reproductive Health and Menopause
MBChB MRCGP DRCOG DFFP
What happens at the Menopause Clinic?
When you make contact we will ask you to complete an online symptom questionnaire. This is confidential and will be stored in your patient notes for the doctor to review.
You may be asked to have some blood tests so that a baseline can be reviewed of your current hormone balance and future improvements monitored along with symptom control.
Your symptoms will be assessed and your previous medical history will be discussed and noted.
You may require and examination and we will assess your Blood Pressure, Height and Weight.
An individual treatment plan will be developed specifically for your symptoms offering tailored HRT where appropriate. This may include oestrogen, testosterone and progesterone.
We can prescribe your medications via our online Pharmacy or you may wish for your GP to be approached to prescribe for you.
Dr Fawcett’s lead of the Menopause Clinic provides a blended approach of hormone replacement therapy, nutritional guidance and lifestyle.
Our patients come from all across the country to seek her specialist advice.
- Hot flushes and sweats
- Aching joints
- Irregular periods
- Vaginal dryness
- Painful sex
- Lack of libido
- Low mood and depression
- Weight gain
- Mood swings
- Loss of collagen (dry hair, nails and skin)
About Hormone Replacement Therapy
It is generally accepted that oestrogens abolish menopausal symptoms, increase bone density, reduce the incidence of heart attacks, strokes and Alzheimer’s disease and improve sexuality.
Oestrogen users also live about 1.5 years longer than non-users. If that is the case acceptance of oestrogen therapy should be simple but it is not. Only about 15% of women at risk take oestrogens and the vast majority abandon HRT within a year. This lack of continuity is due to a combination of things including breast cancer, fear of weight gain, reluctance to have periods or the PMS type symptoms that occur with cyclical progestogen. Also many women taking low does oestrogens do not feel any better and are therefore reluctant to take long-term therapy to prevent a fracture at the age of 85 which may not occur anyway.
There are many new formulations with using various routes of administration, various combinations which attempt to improve the well-being of menopausal women without side-effects or problems of bleeding. Thus therapy is becoming more complicated rather than more simple as we tailor treatment to the needs and response of the individual woman.
Oestrogen therapy for the over 60s is a very important area as these are often neglected in the belief that older osteoporotic bones do not respond to oestrogens. They do and they respond even better than the bones of younger postmenopausal women. In fact the lower the bone density the greater the increase with hormone therapy. It is these women which value low dose oestrogens and no-bleeding regimens. There is a view disputed by many, that oestrogen therapy should only be on ten years’ duration. If this is so it is possible that maximum cardiovascular and skeletal benefits with least side-effects would accrue by starting aged 60 rather than aged 50, but the 50 year old usually requires symptom relief during this decade.
Similarly, HRT for the peri-menopausal woman who is still having periods but suffering from depression, tiredness and loss of libido is another neglected area. These patients often have a long past history of hormone related depression i.e. postnatal depression or pre-menstrual depression.
Such patients suffer their worst depression in the one or two years before their periods stop but often need oestrogens instead of, or as well as, anti-depressant therapy.
Chairman of The British Menopause Society 2005 – 2007